Matthew Douglas Breyer

Chief Scientific Officer, Lead Generation

Eli Lilly and Company Foundation
Country flagUnited States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Matthew Douglas Breyer is the Chief Scientific Officer for Lead Generation at Eli Lilly and Company, located in the United States. His research focuses on kidney disease and the role of various receptors in renal health, as evidenced by his recent articles on AKR1A1, prostacyclin in renal fibrosis, acute kidney injury, and the contributions of cyclooxygenase-2 to diabetic nephropathy. He is also actively involved in leveraging genomics to enhance drug discovery and development for kidney diseases.

Articles (5)

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2020

Collaborators (1)

Raymond Harris

Professor , Director of Research and Associate Program Director, Division of Nephrology

Vanderbilt University Medical Center

UNITED STATES
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.